Skip to main content
. Author manuscript; available in PMC: 2019 Oct 29.
Published in final edited form as: Gynecol Oncol. 2019 Mar 6;153(2):242–247. doi: 10.1016/j.ygyno.2019.03.001

Table 1.

Patient information and tumor characteristics of patients undergoing radical hysterectomy from 2010 to 2016.

Abdominal radical
hysterectomy
Robotic radical
hysterectomy
p-Value

Number of cases 56 49
Mean age (years) 40.6 (±10.7) 44.1 (±10.7) 0.09
Mean BMI 27.6 (±7.1) 28.7 (±6.7) 0.41
Race 0.09
 African American 7 (13%) 14 (29%)
 Caucasian 46 (82%) 34 (69%)
 Other 3 (5%) 1 (2%)
Smoker 0.40
 No 28 (50%) 20 (41%)
 Yes 19 (34%) 23 (47%)
 Former 9 (16%) 6 (12%)
LVSI 0.38
 No 34 (65%) 35 (74%)
 Yes 18 (35%) 12 (26%)
Histology 0.95
 Squamous 32 (57%) 30 (61%)
 Adenocarcinoma 20 (36%) 16 (33%)
 Adenosquamous 4(7%) 3 (6%)
Grade 0.048
 FIGO Grade 1 2 (4%) 8 (16%)
 FIGO Grade 2 37 (66%) 34 (69%)
 FIGO Grade 3 9 (16%) 5 (10%)
 Unknown 8 (14%) 2 (4%)
Size of primary lesion (cm) 0.02
 < 2 cm 21 (38%) 30 (61%)
 ≥ 2 cm 35 (62%) 19 (39%)
Depth of invasion (cm) 0.43
 Superficial (<0.5cm) 15 (27%) 19 (39%)
 Middle (0.5–1 .0cm) 25 (45%) 19 (39%)
 Deep (>1.0cm) 16 (29%) 11 (22%)
Positive Lymph Nodes 0.21
 No 47 (85%) 46 (94%)
 Yes 8 (15%) 3 (6%)
Parametrial involvement 1.0
 No 53 (95%) 46 (94%)
 Yes 3 (5%) 3 (6%)
Vaginal margin involvement 0.41
 No 54 (96%) 45 (93%)
 Yes 2 (4%) 4 (8%)

Bold indicates p-Value of < 0.05